United Therapeutics Reports First Clinical Xenotransplantation in EXPAND Study
United Therapeutics announced the first clinical xenotransplantation in its EXPAND study of the UKidney in patients with end-stage renal disease. The successful transplant operation was performed at NYU Langone Health.
